Ironwood Pharmaceuticals’ (NASDAQ:IRWD) Challenges Continue with Q1 Misses
US$16.33: That's What Analysts Think Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Is Worth After Its Latest Results
Ironwood Pharmaceuticals Reports Mixed Q1 2024 Results Amid Key Clinical Advancements
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
Ironwood Pharmaceuticals Reports Mixed Q1 2024 Results Amid Key Clinical Advancements
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
Ironwood Pharmaceuticals First Quarter 2024 Earnings: US$0.03 loss per share (vs US$0.30 profit in 1Q 2023)
Ironwood Pharmaceuticals Reports First Quarter 2024 Results
Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference
Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference
Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management
Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline
Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline
Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024
Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Biotech Stocks
Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
Analysts Are Bullish on Top Healthcare Stocks: Mediwound (MDWD), Ironwood Pharma (IRWD)
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.